International Stem Cell Trials For Multiple Sclerosis Receive Funding

UK scientists working on the launch of several international trials to investigate the safety and effectiveness of stem cells in slowing or reversing brain and spinal cord damage in people with MS have received 1 million in funds from the MS Society, and the UK Stem Cell Foundation.

Study Identifies Protein that Could Shrink Brain Lesions in Stroke Patients

Researchers at the Stanford School of Medicine published a study in the Proceedings of the National Academy of Sciences that revealed alpha-B-crystallin, a naturally occurring protein, significantly shrank the size of stroke-induced lesions in the brains of laboratory mice, and mitigated the destructiveness of the inflammatory response that follows the stroke.